NO20033700L - Isoksazolinderivater som anti-depressive midler - Google Patents

Isoksazolinderivater som anti-depressive midler

Info

Publication number
NO20033700L
NO20033700L NO20033700A NO20033700A NO20033700L NO 20033700 L NO20033700 L NO 20033700L NO 20033700 A NO20033700 A NO 20033700A NO 20033700 A NO20033700 A NO 20033700A NO 20033700 L NO20033700 L NO 20033700L
Authority
NO
Norway
Prior art keywords
depressants
isoxazoline derivatives
isoxazoline
derivatives
Prior art date
Application number
NO20033700A
Other languages
English (en)
Norwegian (no)
Other versions
NO20033700D0 (no
Inventor
Antonius Adrianus Hendrikus Petrus Megens
Manuel Jesus Alcazar-Vaca
Jose Ignacio Andres-Gil
Jose Maria Cid-Nunez
Joaquin Pastor-Fernandez
Godelieve Irma Christine Heylen
Xavier Jean Michel Langlois
Margaretha Henrica Maria Bakker
Thomas Horst Wolfgang Steckler
Francisco Javier Fernandez-Gadea
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20033700D0 publication Critical patent/NO20033700D0/no
Publication of NO20033700L publication Critical patent/NO20033700L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20033700A 2001-02-21 2003-08-20 Isoksazolinderivater som anti-depressive midler NO20033700L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01200611 2001-02-21
EP01201264 2001-04-05
PCT/EP2002/001567 WO2002066484A1 (en) 2001-02-21 2002-02-13 Isoxazoline derivatives as anti-depressants

Publications (2)

Publication Number Publication Date
NO20033700D0 NO20033700D0 (no) 2003-08-20
NO20033700L true NO20033700L (no) 2003-10-21

Family

ID=26076836

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033700A NO20033700L (no) 2001-02-21 2003-08-20 Isoksazolinderivater som anti-depressive midler

Country Status (33)

Country Link
US (1) US7169786B2 (et)
EP (1) EP1368358B1 (et)
JP (1) JP3953424B2 (et)
KR (1) KR100848898B1 (et)
CN (1) CN100400540C (et)
AR (1) AR035685A1 (et)
AT (1) ATE337322T1 (et)
AU (1) AU2002244717B2 (et)
BG (1) BG107984A (et)
BR (1) BR0207433A (et)
CA (1) CA2437505C (et)
CY (1) CY1106448T1 (et)
CZ (1) CZ20032515A3 (et)
DE (1) DE60214138T2 (et)
DK (1) DK1368358T3 (et)
EA (1) EA006747B1 (et)
EE (1) EE200300398A (et)
EG (1) EG23929A (et)
ES (1) ES2271230T3 (et)
HK (1) HK1065537A1 (et)
HR (1) HRP20030647A2 (et)
HU (1) HUP0303270A3 (et)
IL (2) IL157470A0 (et)
MX (1) MXPA03007432A (et)
MY (1) MY137836A (et)
NO (1) NO20033700L (et)
NZ (1) NZ526741A (et)
PL (1) PL208593B1 (et)
PT (1) PT1368358E (et)
SI (1) SI1368358T1 (et)
SK (1) SK11612003A3 (et)
TW (1) TWI257392B (et)
WO (1) WO2002066484A1 (et)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203299D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel compounds
EP1492796B1 (en) * 2002-04-02 2007-09-05 Janssen Pharmaceutica N.V. Substituted amino isoxazoline derivatives and their use as anti-depressants.
AR040967A1 (es) * 2002-08-12 2005-04-27 Janssen Pharmaceutica Nv Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos
CA2494557C (en) * 2002-08-15 2011-10-18 Janssen Pharmaceutica N.V. Fused heterocyclic isoxazoline derivatives and their use as anti-depressants
WO2004018482A2 (en) * 2002-08-21 2004-03-04 Janssen Pharmaceutica N.V. C6- and c9-substituted chromeno[4, 3-c]isoxazoline derivatives and their use as anti-depressants
WO2004078715A1 (ja) * 2003-03-07 2004-09-16 Astellas Pharma Inc. 2,6-ジ置換スチリルを有する含窒素へテロ環誘導体
EP1944306A1 (en) * 2003-09-17 2008-07-16 Janssen Pharmaceutica, N.V. Fused heterocyclic compounds as serotonin receptor modulators
EA200801812A1 (ru) 2003-09-17 2009-06-30 Янссен Фармацевтика Н.В. Сопряженные гетероциклические соединения
ES2331144T3 (es) * 2004-11-26 2009-12-22 Janssen Pharmaceutica Nv Derivados de isoxazolina-indol con actividad antipsicotica y ansiolitica mejorada.
AU2008226649B2 (en) * 2007-03-09 2013-08-01 Sanofi Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
JP2010529144A (ja) * 2007-06-08 2010-08-26 ヘリコン・セラピューティクス・インコーポレーテッド 治療用ピラゾロキノリン尿素誘導体
WO2009082268A2 (ru) 2007-12-21 2009-07-02 Alla Chem, Llc ЛИГАНДЫ α-АДРЕНОЦЕПТОРОВ, ДОПАМИНОВЫХ, ГИСТАМИНОВЫХ, ИМИДАЗОЛИНОВЫХ И СЕРОТОНИНОВЫХ РЕЦЕПТОРОВ И ИХ ПРИМЕНЕНИЕ
AR078171A1 (es) 2009-09-15 2011-10-19 Sanofi Aventis Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0361577B1 (en) * 1988-09-19 1993-05-05 Akzo N.V. Tetrahydronaphthalene and indane derivatives
US5880121A (en) * 1996-01-05 1999-03-09 Hoechst Marion Roussel Inc. 4,5-dihydronaphth (1,2-c) isoxazoles and derivatives thereof
NZ329954A (en) * 1996-04-12 1999-07-29 Janssen Pharmaceutica Nv Isoxazolidine tetracyclic and tricyclic ring system derivatives and medicaments
HUP9602763A3 (en) * 1996-10-09 1999-05-28 Egyt Gyogyszervegyeszeti Gyar 3-phenyl isoxazole derivatives, process for producing them and pharmaceutical compositions containing the same
ATE259803T1 (de) * 1998-10-09 2004-03-15 Janssen Pharmaceutica Nv 4,5-dehydroisoxazole derivate und ihre pharmazeutische verwendung

Also Published As

Publication number Publication date
PL363264A1 (en) 2004-11-15
EE200300398A (et) 2003-12-15
NO20033700D0 (no) 2003-08-20
SI1368358T1 (sl) 2007-02-28
BR0207433A (pt) 2004-06-01
AR035685A1 (es) 2004-06-23
CA2437505A1 (en) 2002-08-29
NZ526741A (en) 2004-04-30
EP1368358A1 (en) 2003-12-10
DK1368358T3 (da) 2007-01-02
SK11612003A3 (sk) 2004-04-06
IL157470A (en) 2008-07-08
IL157470A0 (en) 2004-03-28
KR100848898B1 (ko) 2008-07-29
JP3953424B2 (ja) 2007-08-08
EP1368358B1 (en) 2006-08-23
EG23929A (en) 2008-01-14
ES2271230T3 (es) 2007-04-16
CZ20032515A3 (cs) 2003-12-17
AU2002244717B2 (en) 2007-07-19
HRP20030647A2 (en) 2005-06-30
CN1492871A (zh) 2004-04-28
MXPA03007432A (es) 2003-11-18
ATE337322T1 (de) 2006-09-15
EA006747B1 (ru) 2006-04-28
HK1065537A1 (en) 2005-02-25
JP2004518748A (ja) 2004-06-24
DE60214138D1 (de) 2006-10-05
CN100400540C (zh) 2008-07-09
TWI257392B (en) 2006-07-01
HUP0303270A2 (hu) 2004-01-28
KR20030076590A (ko) 2003-09-26
US7169786B2 (en) 2007-01-30
PT1368358E (pt) 2007-01-31
CY1106448T1 (el) 2011-10-12
BG107984A (bg) 2004-09-30
HUP0303270A3 (en) 2007-03-28
EA200300915A1 (ru) 2004-06-24
CA2437505C (en) 2010-02-09
PL208593B1 (pl) 2011-05-31
MY137836A (en) 2009-03-31
DE60214138T2 (de) 2007-03-29
WO2002066484A1 (en) 2002-08-29
US20040122037A1 (en) 2004-06-24

Similar Documents

Publication Publication Date Title
DK1414803T3 (da) Pyrazolylcarboxanilider som fungicider
NO20044654L (no) Piperidinoylpiperidiner som 5-HTIF-agonister
DK1608624T3 (da) 6-alkyl eller -alkenyl-4-aminopicolinater som herbicider
NO20035775L (no) 3-fluor-pyrrolidiner som anti-diabetesmidler
DE60211066D1 (de) Gekühltes Schaufelblatt
NO20042955L (no) Substituerte fenylaftalener som estrogene midler
DE50208621D1 (de) Turbomaschine
DK1638928T3 (da) N-alkynyl-2-(substituerede aryloxy)alkylthio-amidderivater som fungicider
NO20044174L (no) Kumariner som er nyttige som biomarkorer
NO20033618L (no) Ftalayinon-piperidino-derivater som PDE-4-inhibitorer
DE602004018602D1 (de) Mikrospiegel
DK1429607T3 (da) Delta-1-pyrroliner som pesticider
ATE459598T1 (de) Sulfonamidderivate
NO20043794L (no) Benzensulfonamidderivater som antipsykotiske midler
NO20033700L (no) Isoksazolinderivater som anti-depressive midler
DK1556377T3 (da) Cyclopropylthienylcarboxamider som fungicider
NO20050127L (no) 9-alfa-substituerte ostratriener som selektivt aktive ostrogener
DE50206249D1 (de) Turbomaschine
DK1442026T3 (da) Triazolderivater som cyclooxygenase (COX)-inhibitorer
NO20041819L (no) Diazacykloalakaner som oksytocinagonister
NO20041455L (no) Zirkonium-/metalloksidfibrer.
NO20033234L (no) Karotenoider som antihypertensjonsmidler
DK1263734T3 (da) 3-thiomethylpyrazoler som pesticider
DE60205178D1 (de) Schwingungsdämpfender Mechanismus
DE60311243D1 (de) Aufwickelvorrichtung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application